# Advancing brain health equity with Indigenous peoples: A critical imperative

**Authors:** Antonia J. Clarke, Cliff Whetung, Astrid Suchy‐Dicey, Adrienne Withall, Kylie Radford, Diane C. Gooding, Louise Lavrencic, Makarena Dudley, Dina Lo Giudice, Leon Flicker, Arantxa Sanchez Boluarte, Sulakshna Aggarwal, Kyle R. Conniff, Amy G. Brodtmann, Monica M. Diaz, Stéfanie A. Tremblay, Emmanuel S. Nwofe, Carey E. Gleason, Kristen Jacklin, Joseph Keawe'aimoku Kaholokula, Chontel Gibson, Juliana Souza‐Talarico, Pamela Roach

PMC · DOI: 10.1002/alz.71125 · Alzheimer's & Dementia · 2026-02-25

## TL;DR

The paper argues that structural inequities and colonization, not biology, cause higher dementia rates in Indigenous communities and calls for culturally grounded approaches to brain health.

## Contribution

It introduces a framework for decolonizing dementia research and policy by centering Indigenous leadership and cultural resilience.

## Key findings

- Dementia disproportionately affects Indigenous populations due to structural inequities and colonization, not biological factors alone.
- Cultural continuity and community leadership are vital for brain health and can serve as neuroprotective resources.
- A shift toward culturally grounded, strengths-based models is needed to advance brain health equity for Indigenous peoples.

## Abstract

Indigenous communities hold rich knowledges, cultural practices, and kinship networks that sustain cognitive resilience and nurture brain health across the life course. Yet these enduring strengths are often obscured by biomedical models that overlook the structural determinants of health—including the cumulative effects of colonization, educational inequity, and socioeconomic disadvantage—that diminish brain health. Accordingly, dementia disproportionately affects Indigenous populations globally, often presenting with earlier onset and higher prevalence compared to non‐Indigenous groups. This perspective synthesizes the current epidemiological evidence, situates dementia risk within its structural and historical context, and explores how Indigenous knowledges, cultural continuity, and community leadership can inform dementia research and care more broadly. Our global insights call for a decisive shift: to decolonize dementia research and policy and move beyond deficit‐based narratives toward approaches that prioritize Indigenous leadership and culturally grounded, strengths‐based pathways to brain health equity.

This perspective synthesizes global evidence on dementia epidemiology among Indigenous populations, examining structural determinants and Indigenous perspectives on brain health and dementia care.Structural inequities and the enduring legacies of colonization, rather than biology alone, underpin the disproportionate dementia burden among Indigenous peoples worldwide.Centering culture, kinship, and connection to land and community reframes brain health beyond biomedical models and reveals cultural resilience as a powerful neuroprotective resource.Key recommendations call for Indigenous leadership and locally tailored, culturally grounded approaches to advance lifelong brain health equity and develop strengths‐based models of dementia care.

This perspective synthesizes global evidence on dementia epidemiology among Indigenous populations, examining structural determinants and Indigenous perspectives on brain health and dementia care.

Structural inequities and the enduring legacies of colonization, rather than biology alone, underpin the disproportionate dementia burden among Indigenous peoples worldwide.

Centering culture, kinship, and connection to land and community reframes brain health beyond biomedical models and reveals cultural resilience as a powerful neuroprotective resource.

Key recommendations call for Indigenous leadership and locally tailored, culturally grounded approaches to advance lifelong brain health equity and develop strengths‐based models of dementia care.

## Linked entities

- **Diseases:** dementia (MONDO:0001627)

## Full-text entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** DEMENTIA (MESH:D003704), amyloid (MESH:C000718787), depression (MESH:D003866), infectious diseases (MESH:D003141), cognitive ageing (MESH:D003072), hypertension (MESH:D006973), brain health (OMIM:603663), obesity (MESH:D009765), white matter abnormalities (MESH:D056784), INTEGRATING (MESH:D000081042), hearing loss (MESH:D034381), pain (MESH:D010146), vision loss (MESH:D014786), cardiometabolic disease (MESH:D024821), neurodegeneration (MESH:D019636), trauma (MESH:D014947), neuroinflammation (MESH:D000090862), anxiety (MESH:D001007), traumatic brain injury (MESH:D000070642), diabetes (MESH:D003920), Alzheimer's Disease (MESH:D000544), neurotoxic (MESH:D020258)
- **Chemicals:** heavy metals (MESH:D019216), alcohol (MESH:D000438), oil (MESH:D009821), cholesterol (MESH:D002784)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933636/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933636/full.md

## References

133 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933636/full.md

---
Source: https://tomesphere.com/paper/PMC12933636